Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients

ClinicalTrials.gov ID: NCT06798909

Public ClinicalTrials.gov record NCT06798909. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Kidney Transplant Preemptive Therapy or Prophylaxis (KPoP) for CMV Prevention in D+R- Recipients

Study identification

NCT ID: NCT06798909
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: University of California, San Francisco; Other
Enrollment: 360 participants

Conditions and interventions

Conditions

Interventions

Valganciclovir (Pre-emptive CMV Therapy) Drug
Valganciclovir CMV Prophylaxis Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 21, 2025
Primary completion: Nov 29, 2030
Completion: May 30, 2031
Last update posted: Mar 31, 2026

2025 – 2031

United States locations

U.S. sites: 5
U.S. states: 5
U.S. cities: 5

Facility	City	State	ZIP	Site status
University of California, San Francisco School of Medicine	San Francisco	California	94117	Recruiting
University of Miami Miller School of Medicine	Miami	Florida	33136	Recruiting
Emory University School of Medicine	Atlanta	Georgia	30322	Recruiting
Robert Wood Johnson Health Network Barnabas Health	Livingston	New Jersey	07039	Recruiting
Medical College of Virginia Commonwealth	Richmond	Virginia	23219	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06798909, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 31, 2026 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06798909 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →